Revenue of $27.9 million, loss per share of $0.26 cents for the third quarter
LOS ALTOS, CALIFORNIA, UNITED STATES – 10/22/2009 – Rambus Inc. (NASDAQ:RMBS), one of the world’s premier technology licensing companies specializing in high-speed memory architectures, today reported financial results for the third quarter of 2009.
Revenue for the third quarter of 2009 was $27.9 million, up 3.3% sequentially from the second quarter of 2009 primarily due to higher variable royalty revenue. As compared to the third quarter of 2008, revenue was down 5.3% primarily due to lower contract revenue. Revenue for the nine months ended September 30, 2009 was $82.2 million, down 21.6% over the same period of last year primarily due to revenue recognized from Elpida during the first half of 2008.
“The recovery in chip sales following an industry overcorrection, and modest growth in our focus markets, helped deliver revenues at the high end of our guidance,” said Harold Hughes, president and chief executive officer at Rambus. “While there is much work ahead, we continue to progress in our strategy of creating and licensing innovations that make great computing and consumer electronics products possible.”
Total costs and expenses for the third quarter of 2009 were $48.5 million, which included $7.7 million of stock-based compensation expenses and $0.1 million for previous stock-based compensation restatement and related legal expenses. This is compared to total costs and expenses of $49.3 million for the second quarter of 2009, which included $7.9 million of stock-based compensation expenses and a net recovery of $0.4 million for previous stock-based compensation restatement and related legal expenses. General litigation expenses for the third quarter were $12.0 million, a decrease of $3.0 million from the second quarter of 2009. Total costs and expenses in the third quarter of last year were $60.0 million, which included $9.0 million of stock-based compensation expenses, $4.0 million of restructuring-related expenses, $2.2 million of asset impairment expenses and $0.4 million of previous stock-based compensation restatement and related legal expenses. General litigation expenses in the third quarter of 2009 decreased $3.7 million from the third quarter of 2008.
Total costs and expenses for the nine months ended September 30, 2009 were $141.4 million, which included $24.0 million of stock-based compensation expenses and a net recovery of $14.0 million for previous stock-based compensation restatement and related legal expenses. This is compared to total costs and expenses of $175.6 million for the same period of 2008, which included $28.5 million of stock-based compensation expenses, $4.0 million of restructuring-related expenses, $2.2 million of asset impairment expenses and $3.6 million of previous stock-based compensation restatement and related legal expenses. General litigation expenses for the nine months ended September 30, 2009 were $45.0 million, an increase of $7.0 million from the same period in 2008.
Interest and other expense, net, for the third quarter of 2009 was $6.8 million as compared to $1.6 million in the second quarter of 2009 and $0.3 million in the third quarter of 2008. Interest and other expense, net, for the nine months ended September 30, 2009 was $9.6 million as compared to interest income of $1.4 million for the same period of 2008. Prior periods have been adjusted to reflect the impact of the adoption on January 1, 2009 of a FASB staff position which clarifies the accounting for convertible debt instruments that may be settled in cash upon conversion, including partial cash settlement. The Company has retrospectively adjusted the income statement to include non-cash interest expense of $3.0 million for the third quarter of 2008 and $8.8 million for nine months ended September 30, 2008.
Net loss for the third quarter of 2009 was $27.5 million as compared to a net loss of $24.0 million in the second quarter of 2009 and a net loss of $30.9 million (adjusted for adoption of the FASB staff position) in the third quarter of 2008. Net loss per share for the third quarter of 2009 was $0.26 as compared to a net loss per share of $0.23 in the second quarter of 2009 and a net loss per share of $0.29 (adjusted for adoption of the FASB staff position) for the third quarter of 2008. Net loss for the nine months ended September 30, 2009 was $68.9 million as compared to a net loss of $183.6 million (adjusted for adoption of the FASB staff position) for the same period of 2008. Net loss per share for the nine months ended September 30, 2009 was $0.66 as compared to a net loss per share of $1.75 (adjusted for adoption of the FASB staff position) in the same period of 2008.
Cash, cash equivalents, and marketable securities as of September 30, 2009 were $498.5 million, up approximately $18.1 million from June 30, 2009 and up approximately $152.6 million from December 31, 2008. During the third quarter of 2009, the Company issued an additional $22.5 million aggregate principal amount of 5% Convertible Senior Notes due 2014 as a result of the underwriters exercising their overallotment option related to the 2014 Notes. During the nine months ended September 30, 2009, the Company received approximately $168.2 million net proceeds related to the issuance of the 5% Convertible Senior Notes, $7.3 million of insurance proceeds related to reimbursement claims associated with the stock option investigation and derivative lawsuits as well as $4.5 million from former executives due to the resolution of the derivative lawsuits.
The convertible notes are carried at face value less the debt discount associated with the adoption of the FASB staff position for the periods presented. As such, the carrying value of the convertible notes as of December 31, 2008 has been retrospectively adjusted to reflect the impact of the adoption of the FASB staff position.
The conference call discussing third quarter 2009 results will be webcast live via the Rambus Investor Relations website (http://investor.rambus.com) at 2:00 p.m. Pacific Time today. A replay will be available following the call on Rambus’ Investor Relations website and for one week at the following numbers: (888) 203-1112 (domestic) or (719) 457-0820 (international) with ID# 5928140.
About Rambus Inc.
Rambus is one of the world’s premier technology licensing companies specializing in the invention and design of high-speed memory architectures. Additional information is available at www.rambus.com.
Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
||
September 30, 2009 | December 31, 2008 | |
Assets | ||
Current assets: | ||
Cash and cash equivalents | $ 367,291 | $ 116,241 |
Marketable securities | 131,192 | 229,612 |
Accounts receivable | 754 | 1,503 |
Prepaids and other current assets | 7,276 | 8,486 |
Deferred taxes | 892 | 88 |
Total current assets | 507,405 | 355,930 |
Restricted cash | 648 | 632 |
Deferred taxes, long-term | 1,069 | 1,857 |
Intangible assets, net | 6,585 | 7,244 |
Property and equipment, net | 15,941 | 22,290 |
Goodwill | 4,454 | 4,454 |
Other assets | 7,653 | 4,963 |
Total assets | $ 543,755 | $ 397,370 |
Liabilities and Stockholders’ Equity | ||
Current liabilities: | ||
Accounts payable | $ 11,162 | $ 6,374 |
Accrued salaries and benefits | 8,458 | 9,859 |
Accrued litigation expenses | 6,220 | 14,265 |
Other accrued liabilities | 5,982 | 3,816 |
Convertible notes | 133,312 | – |
Deferred revenue | 395 | 1,787 |
Total current liabilities | 165,529 | 36,101 |
Long-term liabilities: | ||
Convertible notes | 109,333 | 125,474 |
Other long-term liabilities | 2,297 | 2,854 |
Total long-term liabilities | 111,630 | 128,328 |
Total stockholders’ equity | 266,596 | 232,941 |
Total liabilities and stockholders’ equity | $ 543,755 | $ 397,370 |
Condensed Consolidated Statements of Operations (In thousands, except per share amounts) (Unaudited) |
||||
Three Months Ended September 30 |
Nine Months Ended September 30 |
|||
2009 | 2008 | 2009 | 2008 | |
Revenue: | ||||
Royalties | $ 26,898 | $ 25,793 | $ 77,826 | $ 91,174 |
Contract revenue | 976 | 3,635 | 4,365 | 13,707 |
Total revenue | 27,874 | 29,428 | 82,191 | 104,881 |
Costs and expenses: | ||||
Cost of contract revenue (1) | 1,858 | 4,611 | 5,479 | 18,411 |
Research and development (1) | 16,727 | 17,511 | 50,277 | 59,048 |
Marketing, general and administrative (1) | 29,882 | 31,288 | 99,601 | 88,377 |
Restructuring costs (1) | – | 4,024 | – | 4,024 |
Impairment of asset | – | 2,158 | – | 2,158 |
Costs (recovery) of restatement and related legal activities | 68 | 392 | (14,000) | 3,564 |
Total costs and expenses | 48,535 | 59,984 | 141,357 | 175,582 |
Operating loss | (20,661) | (30,556) | (59,166) | (70,701) |
Interest and other income, net | 891 | 2,704 | 3,504 | 10,207 |
Interest expense | (7,641) | (3,002) | (13,128) | (8,834) |
Interest and other income (expense), net | (6,750) | (298) | (9,624) | 1,373 |
Loss before income taxes | (27,411) | (30,854) | (68,790) | (39,328) |
Provision for income taxes | 85 | 92 | 103 | 114,287 |
Net loss | $ (27,496) | $ (30,946) | $ (68,893) | $ (183,615) |
Net loss per share: | ||||
Basic | $ (0.26) | $ (0.29) | $ (0.66) | $ (1.75) |
Diluted | $ (0.26) | $ (0.29) | $ (0.66) | $ (1.75) |
Weighted average shares used in per share calculation | ||||
Basic | 105,182 | 104,897 | 104,761 | 104,795 |
Diluted | 105,182 | 104,897 | 104,761 | 104,795 |
(1) Total stock-based compensation expense for the three and nine month periods ended September 30, 2009 and September 30, 2008 are presented as follows: | ||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||
2009 | 2008 | 2009 | 2008 | |
Cost of contract revenue | $ 283 | $ 1,321 | $ 906 | $ 4,604 |
Research and development | $ 2,332 | $ 3,326 | $ 7,286 | $ 10,997 |
Marketing, general and administrative | $ 5,134 | $ 4,371 | $ 15,826 | $ 12,899 |
Restructuring costs | $ – | $ 547 | $ – | $ 547 |